Skip to main content
ACG 2025 Annual Meeting Main banner

Mazen Noureddin, MD, MHSc

Professor of Medicine
Houston Methodist Hospital
Houston, TX

Mazen Noureddin, MD, MHSc, is a Professor of Medicine at Houston Methodist Hospital’s Underwood Center for Digestive Disorders and the Conover Center for Liver Disease & Transplantation. He also serves as Chief Scientific Officer and Co-Chairman of the Board for both Summit Clinical Research and Pinnacle Clinical Research. In 2022, he founded the Houston Research Institute, a state-of-the-art facility providing innovative, non-invasive diagnostic tools and therapies for patients with liver disease. Dr. Noureddin completed his internal medicine residency at the University of Southern California, followed by a three-year hepatology fellowship at the National Institutes of Health (NIH), where he also earned a Master of Health Sciences in Clinical Research through the NIH/Duke program. He then pursued a gastroenterology fellowship at the University of California, San Diego, as a T32 NIH fellow. His academic career began at USC as an Assistant Professor of Clinical Medicine in 2013. In 2015, he was recruited to Cedars-Sinai Medical Center, where he became the founding director of the Fatty Liver Program. Dr. Noureddin is internationally recognized for his work in MASLD/MASH and MASH-related cirrhosis. He has led over 80 clinical trials investigating novel treatments and is considered a leading expert in non-invasive testing and biomarkers. He has contributed extensively to national and international consensus panels and is Chair of the AASLD MASLD Special Interest Group. He has served on editorial boards for leading journals including Gastroenterology, Hepatology, and Clinical Gastroenterology and Hepatology, where he is also Associate Editor. He has authored more than 300 publications in top-tier journals such as The New England Journal of Medicine, The Lancet, Nature Medicine, and Science Translational Medicine. He has also received funding from the National Cancer Institute and served on NIH study sections.

Presentation(s):